A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Herantis Pharma Plc: Change in the number of shares and voting rights

Herantis Pharma Plc: Change in the number of shares and voting rights Herantis Pharma Plc Company release 22 March 2019…

Read More

Herantis Pharma’s Annual Report 2018 published

Herantis Pharma’s Annual Report 2018 published Herantis Pharma Plc Company release 20 March 2019 at 9:00 am Herantis Pharma Plc’s…

Read More

Notice to convene Herantis Pharma Plc’s Annual General Meeting of shareholders

Notice to convene Herantis Pharma Plc’s Annual General Meeting of shareholders Herantis Pharma Plc Company release 15 March 2019 at…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.